blindness glp 1 GLP-1 Agonists—commonly used for weight loss and diabetes—are now being linked to serious eye health concerns, including an increased risk of a condition called NAION, which can cause irreversible blindness. With GLP-1 Gastroparesis and Ozempic: Understanding cat::Metabolism Quantity:1-Bottle

blindness glp 1 GLP-1 Agonists—commonly used for weight loss and diabetes—are now being linked to serious eye health concerns, including an increased risk of a condition called NAION, which can cause irreversible blindness. With GLP-1 Gastroparesis and Ozempic: Understanding cat::Metabolism Quantity:1-Bottle

Gastroparesis and Ozempic: Understanding Stomach Paralysis | Dr Hagmeyer

[6] Preclinical studies in animal models suggest that GLP-1 receptor activation may: Promote neuroplasticity and neurogenesis (formation of new neurons) in the hippocampus, a region often showing reduced volume in depression Modulate neurotransmitter systems , particularly dopamine and serotonin pathways involved in mood regulation and reward processing Reduce neuroinflammation , which is increasingly recognised as contributing to depressive disorders Enhance brain-derived neurotrophic factor (BDNF) expression, a protein crucial for neuronal health and resilience Metabolic improvements associated with GLP-1 therapy may also contribute indirectly to mood benefits

cat::Metabolism

Quantity:1-Bottle

Type 2 diabetes is associated with chronic inflammation, insulin resistance, and elevated insulin levels, all of which have been linked to poorer outcomes in several cancers, including breast cancer